September 20, 2011
Moneycontrol.comMatrix gets FDA approval for AIDS drugBizjournals.comMatrix's new co-pack offers a single day's treatment for HIV/AIDS, helping patients comply with what often can be a burdensome drug regimen. Mylan Inc. (Nasdaq:MYL) subsidiary Matrix Laboratories Ltd. has received tentative approval from the Food and …Mylan's Matrix Receives Tentative FDA Approval Through PEPFAR for Novel "Co …MarketWatch [...]
Tags: AIDS, Approval, Bizjournals.com, Drug, gets, Matrix
Posted in FDA | No Comments »
September 20, 2011
French TribuneFDA adds 2 more approved uses for Amgen's ProliaBusinessWeekBiotechnology company Amgen Inc. said Monday the Food and Drug Administration has approved its osteoporosis treatment Prolia to help make bones stronger in some cancer patients who have had chemotherapy. The Thousand Oaks, Calif., company said …FDA Okays Denosumab for Cancer-Induced Bone LossMedPage TodayFDA approves 2 [...]
Tags: adds, Amgen's, approved, BusinessWeek, More, Prolia, uses
Posted in FDA | No Comments »
September 20, 2011
Fox NewsFDA confirms Listeria outbreak is linked to cantaloupe grown at Colorado farmWashington PostThe FDA identified Jensen Farms, a family-owned operation that says it has grown cantaloupe for two decades, as the source of melons contaminated with a strain of Listeria, a dangerous but uncommon bacteria that thrives in cool temperatures. …FDA: Jensen Farms' Listeria [...]
Tags: cantaloupe, Colorado, confirms, Farm, grown, Linked, Listeria, Outbreak, Post, Washington
Posted in FDA | No Comments »
September 20, 2011
FDA Approves Watson Pharmaceuticals Generic Lovenox (Enoxaparin)ForbesThe FDA has granted approval to Amphastar's generic version of Lovenox (enoxaparin sodium), Watson Pharmaceuticals has announced. The low molecular weight heparin will be sold by Watson under an arrangement with Amphastar. In July the FDA approved the …FDA Approves Amphastar's Generic LovenoxWall Street JournalMomenta Falls After FDA Clears [...]
Tags: approves, Enoxaparin, Forbes, Generic, Lovenox, Pharmaceuticals, Watson
Posted in FDA | No Comments »
September 19, 2011
New York Daily NewsWhy You Should Trust The FDA (And Not Dr. Oz)ForbesIf the reaction in the news media to Dr. Oz's absurd claims about the dangers of arsenic in apple juice has been enormously heartening (essentially the media's collective “Dr. Oz says this, but the FDA says that” narrative leaves the celebrity …Sen. Schumer [...]
Tags: Forbes, Should, Trust
Posted in FDA | No Comments »
September 19, 2011
FDA Approves Amphastar's Generic LovenoxWall Street JournalFDA officials "have concluded that adequate information has been presented to demonstrate that the drug is safe and effective for use as recommended" and "is therapeutically equivalent" to the original Lovenox, the FDA's letter to Amphastar said. …Momenta Falls After FDA Clears Amphastar's Lovenox GenericBusinessWeekWatson Pharmaceuticals Announces Approval of [...]
Tags: Amphastar's, approves, Generic, Journal, Lovenox, Street, Wall
Posted in FDA | No Comments »
September 19, 2011
ThirdAgeFDA Approves Denosumab for Patients With CancerMedscapeas a treatment to increase bone mass in men at high risk for fracture who are receiving androgen deprivation therapy for nonmetastatic prostate cancer. "Bone loss and fractures are recognized adverse effects of hormone ablation therapies, …FDA clears Amgen bone drug for cancer patientsReutersFDA Okays Denosumab for Cancer-Induced Bone [...]
Tags: approves, cancer, Denosumab, Medscape, patients
Posted in FDA | No Comments »
September 18, 2011
MedIndiaEASD: Debate Brings Incretin Risks to ForefrontMedPage TodayThe findings were based on an analysis of data from the FDA's Adverse Event Reporting System (AERS), which is known to have several limitations, as pointed out by debate opponent Michael Nauck, MD, of the Diabetes Center Bad Lauterberg in Harz, …Possible link between diabetes drugs, cancerToronto SunTwo [...]
Tags: brings, Debate, EASD, Forefront, Incretin, MedPage, Risks, Today
Posted in FDA | No Comments »
September 18, 2011
Zee NewsFDA Conducting Safety Review Of Anti-Nausea Drug ZofranWall Street JournalFDA said Zofran might raise the risk of developing abnormal changes in the electrical activity of the heart, which can cause abnormal and potentially fatal heart rhythms. FDA said GlaxoSmithKline is currently conducting a study on whether Zofran …Anti-nausea drug may pose risk to heart [...]
Tags: AntiNausea, Conducting, Drug, Journal, Review, Safety, Street, Wall, Zofran
Posted in FDA | No Comments »
September 18, 2011
FDA Officials Slam Corn Industry over HFCS ClaimsFood and Drink DigitalBut documents uncovered by the Associated Press prove that, even if the courts rule in their favor over their ad campaign, the Corn Refiners Association could still have a hard time winning any arguments with the FDA. According to an exclusive report …and more » fda [...]
Tags: Claims, Corn, Digital, drink, Food, HFCS, Industry, officials, over, Slam
Posted in FDA | No Comments »